Stay updated on XmAb®18087 in NET and GIST Clinical Trial

Sign up to get notified when there's something new on the XmAb®18087 in NET and GIST Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XmAb®18087 in NET and GIST Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding lapse notice and the prior Revision: v3.4.1 notice.
    Difference
    0.4%
    Check dated 2026-02-11T02:17:30.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now displays a government funding lapse notice and a version update (Revision: v3.4.1), replacing the prior version (v3.4.0); These changes do not modify core study content such as the study data, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T00:42:55.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The changes are limited to page metadata and UI elements (Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0) and do not modify core trial details such as eligibility, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:17:09.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision note updated from v3.3.3 to v3.3.4; the page footer now displays the revised version. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:54:28.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    A new 'Locations' section lists all study sites by state (Arizona, California, Colorado, Florida, Georgia, Illinois, Massachusetts, Minnesota, New York, Ohio, Pennsylvania, Texas, and Virginia). The old state-specific location headings were removed, and a footer entry shows Revision: v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T13:34:23.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2, affecting only metadata; there are no changes to study content, eligibility, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T18:47:43.000Z thumbnail image

Stay in the know with updates to XmAb®18087 in NET and GIST Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XmAb®18087 in NET and GIST Clinical Trial page.